Tag Archive | "frequent urination"

Solifenacen May Improve Sleep-Related Quality of Life for Overactive Bladder and Nocturia Patients

Adults who have an overactive bladder and nocturia might benefit from solifenacin, which may improve quality of sleep and sleep-related quality of life by decreasing the number of overnight trips to the bathroom and increasing the amount of urination per trip.  Solifenacin is a urinary antispasmodic approved by the US Food and Drug Administration (FDA) for use in adults in 2005.  It works by relaxing bladder muscles to prevent urgent, frequent, or uncontrolled urination.

These new findings come from a subgroup exploratory analysis of 962 Japanese men and women, 20 years or older with overactive bladder and nocturia, who participated in a randomized, controlled 12-week trial study evaluating solifenacen (5 and 10 milligrams) against a placebo.  Only participants who urinated at least once overnight were included in the analysis.  The participants recorded their results in a bladder diary.  While the decrease in nocturia was statistically significant for those given 10 milligrams of solifenacen, the results were not statistically significant for those given 5 milligrams.

Both the 5mg and 10mg dose significantly increased the amount of urination per trip to the bathroom by 30 and 41 milliliters, respectively.  With both doses, the amount of undisturbed sleep time increased by an average of 59 and 60 minutes, respectively, compared to 33 minutes with the placebo.  The study showed most significant improvements in sleep-related quality of life.  Because of the exploratory nature of this study, the authors of the Journal of Urology report caution that the results need to be interpreted with caution.  The analysis was supported by Astellas Pharma Inc.

Posted in Bladder TreatmentComments Off

Research Study for Treatment of Lower Urinary Tract Symptoms (LUTS) Due To Benign Prostatic Hyperplasia (BPH)

Are you a man age 50 or older?

Do you have to urinate frequently during the day and at night?

Do you have trouble urinating?

Are these and other urinary problems interfering with your life and your relationships?

If you answered “yes” to the above questions, you may be a candidate for the L.I.F.T. Study.

The L.I.F.T. Study is an FDA approved research study to evaluate the UroLift system to support a premarketing application to FDA.  Its purpose is to determine the safety and effectiveness of the UroLift system for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).  The study is being conducted at urology practices throughout the U.S., in Canada and in Australia.

BPH is a non cancerous condition that causes the prostate to enlarge as men age.  When the enlarged prostate presses on the urethra, it can cause bothersome urinary symptoms. The UroLift System is a minimally invasive approach to treating BPH that lifts/holds the enlarged prostate tissue out of the way so it no longer blocks the urethra.  There is no cutting, heating or removal of prostate tissue. The goal of UroLift system treatment is to relieve symptoms so you can get back to your life and resume your daily activities.

The UroLift system is an investigational device as such is limited by Federal Law to investigational use only.

To find out more about L.I.F.T. Study and UroLift system treatment and study locations, go to www.neotract.com.

Posted in Bladder TreatmentComments Off